We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Another Key Gene Discovered for Alzheimer’s Disease

By LabMedica International staff writers
Posted on 05 Oct 2017
The consensus among scientists has been that the Apolipoprotein E (ApoE4) gene is the main marker of Alzheimer's disease and many other dementias, but a new study has added another key player into the mix.

The ApoE gene is instrumental in forming lipoproteins, which are molecules that carry cholesterol and other fats through our bloodstream. More...
ApoE has several slightly different versions, and one of them, called e4, has been strongly associated with the risk of developing Alzheimer's disease. Moreover, the ApoE4 gene is linked to the buildup of amyloid plaque, which is a clumpy protein found in the brain tissue of Alzheimer's patients.

A group of international scientists led by those at the University of Southern California (Los Angeles, CA, USA) interviewed participants once every two years between 1996 and 2012, and another group did so between 2002 and 2012. For the test of immediate recall, the participants were read a list of 10 nouns and were asked to say them back to the interviewer immediately. But for the delayed recall test, the interviewer waited five minutes before asking participants to repeat the list.

The team adjusted the data for age and sex also examined the genetic data from 7,486 American participants and 6,898 European participants. In 2006, the first wave was collected from buccal swabs using the Qiagen Autopure method. In 2008, the second wave was collected using Oragene saliva kits and extraction method. Both waves were genotyped using the HumanOmni2.5-4v1 array.

Overall, the scientists examined 1.2 million genetic variations in the human genome, looking for associations between these gene variations and the results of the memory tests. Only the Translocase of Outer Mitochondrial Membrane 40 (TOMM40) gene was found to be strongly associated with a decline in immediate and delayed recall. The results also showed an association with the "traditional" genetic culprit, ApoE4, but the link was not as strong. Additionally, the analysis revealed that the e3 variant of the ApoE gene was also associated with a low memory score, when found in conjunction with the TOMM40 gene.

Carol A. Prescott, PhD, a professor of Psychology and senior author of the study said, “Our findings indicate that TOMM40 plays a larger role, specifically, in the decline of verbal learning after age 60. Other studies may not have detected the effects of TOMM40. The results from this study provide more evidence that the causes of memory decline are even more complicated than we thought before, and they raise the question of how many findings in other studies have been attributed to ApoE4 that may be due to TOMM40 or a combination of TOMM40 and ApoE4.” The study was published on August 11, 2017, in the journal Public Library of Science ONE.

Related Links:
University of Southern California


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
High-Density Lipoprotein Containing Cholesterol Assay
HDL-c direct FS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.